Literature DB >> 18407143

Growth hormone-insulinlike growth factor I and immune function.

M C Gelato1.   

Abstract

Growth hormone (GH) and insulinlike growth factor I (IGF-I) may be part of a neuroendocrine immune axis that stimulates cellular proliferation of primary lymphoid organs (bone marrow, thymus) as well as stimulates activation of peripheral lymphocytes and macrophages to enhance specific immune responses. GH can also stimulate production of thymic hormones and cytokines, and in this way impact on immune function. It is not clear whether GH and IGF-I act independently or whether the action of GH is mediated by local production of IGF-I by lymphocytes. Both GH and IGF-I and their receptors are present in lymphocytes. Thus, cells of the immune system may be important targets of the GH-IGF-I axis.

Entities:  

Year:  1993        PMID: 18407143     DOI: 10.1016/1043-2760(93)90088-v

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  3 in total

1.  Superoxide anion release from neutrophils in growth hormone deficient adults before and after replacement therapy with recombinant human growth hormone.

Authors:  N Reinisch; P Schratzberger; G Finkenstedt; C M Kähler; C J Wiedermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

2.  Expression of the growth hormone gene in immune tissues.

Authors:  C L Render; K L Hull; S Harvey
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

3.  Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro.

Authors:  James Keane; Lotti Tajouri; Bon Gray
Journal:  Nutr Metab (Lond)       Date:  2016-07-04       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.